Can We Avoid Axillary Lymph Node Dissection (ALND) in Patients with 1–2 Positive Sentinel/Low Axillary Lymph Nodes (SLN/LAS+) in the Indian Setting?

The ACOSOG Z0011 study, heralded as a “practice changing” trial, suggested that women with T1–2 breast cancer with 1–2 SLN+, undergoing breast conservation therapy, need not be offered further ALND. However, whether these results are applicable to all women in the Indian setting, it remains debatabl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Surg Oncol
Main Authors: Reddy, A., Nair, Nita S., Mokal, Smruti, Parmar, V., Shet, T., Pathak, R., Chitkara, G., Thakkar, P., Joshi, S., Badwe, R. A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer India 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8272788/
https://ncbi.nlm.nih.gov/pubmed/34295070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13193-021-01297-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados